SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Target Specialty Products, a leading provider of Pest and Vector Control and Turf and Ornamental solutions in the U.S. and Canada, will be the exclusive distributor for Imperium – a new aerial mosquito-control solution from Bayer.
Bayer continues to invest heavily in ground-breaking solutions, ongoing research, training, and education to help Mosquito Control Professionals around the globe fight against mosquitoes that may carry disease. Imperium, the company’s latest innovation, is an aerial insecticide that utilizes patented formulation technology to deliver superior efficacy with low application rates, reduced impact, and an all-crop tolerance.
Imperium is also the first and only Type II pyrethroid (Deltamethrin) registered in the United States for wide area mosquito control. Deltamethrin has been proven to effectively control resistant mosquitoes in nationwide testing. The benefits of the product include:
Superior efficacy with low application rates
Imperium provides excellent control and knockdown using low application rates – up to 80 times less active ingredient than other products. This significantly reduces the amount of pesticide released into the environment.
Low impact, noncorrosive
In the public health sector, safety is a top priority. Because Imperium is non-corrosive and has no PBO and no VOCs, it provides peace of mind with reduced impact for applicators, the public and the environment.
All crop tolerance
Imperium is labeled for application over any and all crops including range and pasture lands. This gives mosquito abatement professionals the flexibility to control mosquitoes in a wide variety of environments.
Effective against resistant mosquitoes
Imperium is the only Type-II pyrethroid labeled for wide-area mosquito control. Its chemistry and advanced formulation provide exceptional control of mosquitoes with demonstrated resistance to other pyrethroids and/or organophosphates. Tested by public health officials across the country, Imperium is effective against numerous species of mosquitoes including those that may carry Zika, Dengue, Chikungunya, and West Nile viruses.
“We continue to build on our close relationship with Bayer to bring to market the latest solutions to deliver proven control of mosquitoes, developed with reduced environmental impact and safety in mind,” said David Helt, President of Target Specialty Products. “Imperium is the most advanced product in its class and we believe our customers will be excited to add this innovative product to fight against mosquitoes effectively.”
“We are very excited to offer Imperium through Target Specialty Products,” said Dr. Kurt Vandock, Head of Public Health for Bayer. “Imperium is a great example of how, at Bayer, our passion for protecting public health can result in a novel solution that is innovative, effective, and aligned with our global commitment to environmental stewardship.”
To help deliver this new innovation to the market, Bayer has partnered exclusively with Target Specialty Products to be the sole distributor of Imperium. Target Specialty brings experience and expertise in the area of aerial applications, along with an energetic team that will help deliver a successful solution to our customers.
Target Specialty Products continues to experience exceptional growth and will continue its expansion throughout North America, expanding its footprint and customer service efforts across the West, Midwest, and East Coast regions.
About Target Specialty Products
With over 80 years of industry experience, Target Specialty Products is proud to be a leading value-added solution and service provider of pest management, vector control, and turf and ornamental solutions. Target Specialty Products continues to serve the pest, vector, and turf and ornamental management markets from 43 locations across the United States and Canada. For additional information, visit us at www.target-specialty.com.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.